CYP 0.00% 27.0¢ cynata therapeutics limited

Ann: Cynata confirms receipt of indicative non-binding proposal, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 25 Posts.
    “In response to the ASX Price Query, Cynata confirms that it has received an indicative, non-binding and conditional proposal from Sumitomo Dainippon Pharma Co., Ltd (“Sumitomo”) regarding a possible acquisition of all of the shares in Cynata at a price of A$2.00 per share in cash by way of a scheme of arrangement (the “Proposal”).“
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.